Status:
COMPLETED
Understanding COVID-19
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
University of Geneva, Switzerland
Conditions:
SARS-CoV-2 Viral Kinetics and Host Immune Responses
Eligibility:
All Genders
Brief Summary
This single-center prospective observational study will examine immune responses to to SARS-CoV-2 and how they correlate with its virological characteristics and clinical manifestations in infected pa...
Detailed Description
The primary aim of this single-center prospective observational study is to establish how immune responses to SARS-CoV-2 or to cross-reactive viruses correlate with the virological and clinical charac...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The following persons may be included:
- A patient of any age meeting the European Centre for Disease Control and Prevention's confirmed case definition: "A person with laboratory confirmation of virus causing COVID-19, irrespective of clinical signs and symptoms" (and/or high suspicion/actively being treated as CoVID+ cases pending test confirmation)
- Household contacts (defined as those sleeping in the same apartment/house as an infected patient) of a patient with laboratory-confirmed COVID-19 (and/or high suspicion/actively being treated as CoVID+ cases pending test confirmation), whether symptomatic or not, and whether testing positive or not during a period of 14 days
- Exclusion Criterion:
- Long-term incapacity leading to the inability to provide informed consent while not having a patient representative with the ability to provide informed consent
Exclusion
Key Trial Info
Start Date :
March 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04329546
Start Date
March 27 2020
End Date
December 31 2021
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Geneva
Geneva, Switzerland, 1211